More delay for Boston biolab

Additional safety studies for Boston's planned Biosafety Level 4 lab, demanded by the Massachusetts Supreme Court last year, will further delay the opening of the facility, according to court documents filed by the NIH this week. In November, 2007, an outside scientific panel linkurl:concluded;http://www.the-scientist.com/blog/display/53944/ that the NIH had flubbed the safety evaluations for the lab, and in December, the Massachusetts Supreme Court linkurl:ruled;http://www.the-scientist.com/bl

By | February 1, 2008

Additional safety studies for Boston's planned Biosafety Level 4 lab, demanded by the Massachusetts Supreme Court last year, will further delay the opening of the facility, according to court documents filed by the NIH this week. In November, 2007, an outside scientific panel linkurl:concluded;http://www.the-scientist.com/blog/display/53944/ that the NIH had flubbed the safety evaluations for the lab, and in December, the Massachusetts Supreme Court linkurl:ruled;http://www.the-scientist.com/blog/display/54019/ that further safety studies were needed before the lab could open. According to the court documents, the NIH estimates it will release the results of the new study "on or before April 30, 2009." A lawyer for the Conservation Law Foundation, which linkurl:sued the NIH;http://www.the-scientist.com/news/display/23468/ in 2006 to stop the lab, told the Boston Globe in an linkurl:article today;http://www.boston.com/news/health/blog/2008/01/federal_review.html that the delays could mean that the lab won't be able to open until early 2010. University spokeswoman Ellen Berlin told The Scientist that BU "completely supports" the agency's further safety evaluation, and that it was too soon to estimate the timing for the biolab's opening.

Popular Now

  1. Major German Universities Cancel Elsevier Contracts
  2. Running on Empty
    Features Running on Empty

    Regularly taking breaks from eating—for hours or days—can trigger changes both expected, such as in metabolic dynamics and inflammation, and surprising, as in immune system function and cancer progression.

  3. Most of Human Genome Nonfunctional: Study
  4. Identifying Predatory Publishers
AAAS